TY  - SOUND
AU  - Holgate,S.T.
TI  - INFbeta therapy for COVID-19: the new SNG001 drug 
T2  - Interviews on Covid-19,
PY  - 2020///
CY  - London
PB  - Henry Stewart Talks
KW  - Antiviral agents
KW  - Development
KW  - Clinical trials
KW  - Coronavirus infections
KW  - Chemotherapy
KW  - COVID-19 (Disease)
KW  - Treatment
KW  - Interferon
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Clinical Trials as Topic
KW  - COVID-19
KW  - drug therapy
KW  - Drug Delivery Systems
KW  - Interferon-beta
KW  - therapeutic use
KW  - Nebulizers and Vaporizers
KW  - SARS-CoV-2
KW  - Treatment Outcome
N1  - Audio interview; Title from title frames; Contents: Why INFβ was chosen as a therapy for COVID-19 -- Previous use of INFβ by inhalation -- Safety of INFβ as a therapy -- SNG001 mode of delivery  -- SNG001 clinical trials and future prospects; Access restricted to subscribers
UR  - https://hstalks.com/bs/4301
UR  - https://hstalks.com/bs/p/1060/
ER  -